VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Aug. 11, 2006) - WEX Pharmaceuticals Inc. (the “Company”) (TSX:WXI) - Earlier this week, two shareholders of the Company who hold in the aggregate less than one-half of one percent of the outstanding shares (the “Dissidents”) launched proceedings against the Company following the Company’s decision to provide its shareholders with a fair opportunity to evaluate responses to matters raised by the Dissidents in response to the Company’s decision to reschedule its Annual General Meeting to September 29, 2006.
